Top Markets
#1 GENIUS AI GENIUS AI +167.52%
#2 Siren Siren +17.98%
#3 WAX WAX +15.05%
#4 Cloud Cloud +11.86%
#5 GXChain GXChain +9.63%
#6 Giggle Fund Giggle Fund +9.45%
#7 Strategic Oil Supply Strategic Oil Supply +8.98%
#8 SmarDex SmarDex +8.60%
#9 ZetaChain ZetaChain +8.55%
#10 StakeStone StakeStone +7.88%
Coin of the day
GENIUS AI GENIUS AI
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Clasificación en acciones #93
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and... Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Precio por acción
$137.21
Capitalización bursátil
$170.34B
Cambio (1 día)
-2.76%
Cambio (1 año)
28.14%
País
US
Comercio Gilead Sciences, Inc. (GILD)

Categoría

Healthcare
Historial de rendimiento por dividendo de Gilead Sciences, Inc. (GILD)
Rendimiento por dividendo (TTM) de Gilead Sciences, Inc. (símbolo bursátil: GILD) al 2024-12-31: 3.40%
Rendimiento promedio por dividendo de los últimos 5 años: 3.43%
Historial de rendimiento por dividendo de Gilead Sciences, Inc. (GILD) desde 2000 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
2026 (TTM) 2.20% -14.40%
2025 2.57% -24.41%
2024 3.40% -9.81%
2023 3.77% 9.59%
2022 3.44% -12.91%
2021 3.95% -16.14%
2020 4.71% 20.77%
2019 3.90% 6.56%
2018 3.66% 25.34%
2017 2.92% 14.06%
2016 2.56% 101.57%
2015 1.27% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
2010 0.00% 0.00%
2009 0.00% 0.00%
2008 0.00% 0.00%
2007 0.00% 0.00%
2006 0.00% 0.00%
2005 0.00% 0.00%
2004 0.00% 0.00%
2003 0.00% 0.00%
2002 0.00% 0.00%
2001 0.00% 0.00%
2000 0.00% 0.00%
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
0.63%
US
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
1.64%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
2.15%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
3.03%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
3.05%
CH